| Patient | Albert Einstein |
|---|---|
| Date of birth | 1956-03-14 |
| Identifiers | MRN HR-ET012-SYN; SSN (made up) 000-12-6650 |
| Document date | 2026-09-22 |
| Author | Clementine Ward, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Six-month aneurysm surveillance. [S]
Mr. Einstein returns six months after his first visit for surveillance duplex ultrasound, done in the vascular laboratory this morning. He has had no abdominal, back, flank, or groin pain, fainting, or leg symptoms. He finished the 7 mg nicotine patch this week and has used only an occasional lozenge, and has had no tobacco for nearly six months. His home blood pressure readings average 122/74. He takes amlodipine, losartan, atorvastatin, and aspirin without side effects. He has booked his eye examination and plans to have his influenza and COVID-19 vaccines at the pharmacy next week. He asked for the numbers in full and wanted to know whether anything in today's results changes the plan agreed in April. [S]
| Element | Detail |
|---|---|
| Aneurysm | 5.1 cm by duplex ultrasound today; 5.0 cm six months ago |
| Symptoms | None |
| Tobacco | Tobacco-free nearly six months; nicotine replacement finished |
| Blood pressure | Home average 122/74 |
| System | Result | Finding |
|---|---|---|
| Cardiovascular | Negative | No fainting, chest pain, or leg pain on walking |
| Gastrointestinal | Negative | No abdominal pain |
| Musculoskeletal | Negative | No back or flank pain; no muscle aches |
| Respiratory | Negative | No cough |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Amlodipine 5 mg oral tablet, one tablet daily | One tablet by mouth each morning | Oral route | 2025-05-20 | active | S |
| Losartan 50 mg oral tablet, one tablet daily | One tablet by mouth each morning | Oral route | 2026-03-24 to 2026-04-21 | completed | S |
| Losartan 100 mg oral tablet, one tablet daily | One tablet by mouth each morning | Oral route | 2026-04-21 | active | S |
| Atorvastatin 40 mg oral tablet, one tablet daily | One tablet by mouth each evening | Oral route | 2026-03-24 | active | S |
| Aspirin 81 mg delayed-release oral tablet, one tablet daily | One tablet by mouth daily with food | Oral route | 2026-04-21 | active | S |
| Nicotine 14 mg/24 hour transdermal patch, one patch daily | Apply one new patch each morning | Topical route | 2026-03-24 to 2026-07-14 | completed | S |
| Nicotine 7 mg/24 hour transdermal patch, one patch daily | Apply one new patch each morning | Topical route | 2026-07-14 to 2026-09-22 | completed | S |
| Nicotine 2 mg lozenge as needed for cravings | Dissolve one lozenge in the mouth for a craving, no more often than every 2 hours and no more than 20 a day | Oral route | 2026-03-24 to 2026-09-22 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-09-22 | Body height | 172 | cm | S |
| 2026-09-22 | Body weight | 79.8 | kg | S |
| 2026-09-22 | Body mass index (BMI) [Ratio] | 27 | kg/m2 | S |
| 2026-09-22 | Systolic blood pressure | 124 | mm[Hg] | S |
| 2026-09-22 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 2026-09-22 | Heart rate | 66 | /min | S |
| 2026-09-22 | Respiratory rate | 14 | /min | S |
| 2026-09-22 | Body temperature | 36.6 | Cel | S |
| 2026-09-22 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-09-22 | Aorta Diameter by US | 5.1 | cm | <=3 cm | High | S |
Vital signs recorded on 2026-09-22; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; weight 79.8 kg |
| Cardiovascular | Regular rhythm at 66 per minute; blood pressure 124/76 mmHg; femoral, popliteal, and foot pulses normal |
| Abdomen | Pulsatile, non-tender mass above the umbilicus |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Infrarenal abdominal aortic aneurysm, 5.0 cm by duplex ultrasound, found and wrapped at a prior exploratory laparotomy; under surveillance below the repair threshold | active | confirmed | I71.43 | S — Synthetic modern coding anchored to the documented aneurysm found and wrapped at his exploratory laparotomy; the diameter and all surveillance are synthetic. |
| Essential hypertension | active | confirmed | I10 | S — Synthetic risk factor in the modern frame; no historical blood pressure is documented in the cited sources. |
| Nicotine dependence, pipe tobacco | active | confirmed | F17.290 | S — Synthetic modern coding anchored to his documented pipe smoking. |
| Atherosclerosis of the abdominal aorta, with calcified atheroma on CT angiography | active | confirmed | I70.0 | S — Synthetic finding on the baseline CT angiography. |
| Acute low back strain after lifting, with aneurysm symptoms excluded; resolved | resolved | confirmed | S39.012A | S — Synthetic intercurrent illness at an unscheduled visit, chosen to teach how new back pain is assessed in a patient with a known aneurysm. It does not echo a documented illness. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Imaging | Aneurysm diameter by duplex ultrasound (CT if views are poor) | Every 6 months at 5.0 to 5.4 cm in men; yearly at 4.0 to 4.9 cm | Completed today | 5.1 cm today, 5.0 cm six months ago: growth 0.1 cm; next scan in six months |
| Imaging | CT angiography for baseline anatomy and repair planning | Once at baseline; again when repair is considered | Up to date | Baseline done; repeat only if repair is considered |
| Examination | Femoral and popliteal arteries for a coexisting aneurysm | Once at diagnosis | Completed today | Popliteal duplex with today's scan: 0.8 cm on each side, no aneurysm |
| Examination | Aneurysm symptoms and tenderness, with the emergency plan reviewed | Every visit | Completed today | No symptoms; non-tender; emergency plan reviewed |
| Referral | Vascular surgery review and shared decision on elective repair | At baseline, then at a threshold change or yearly | Completed today | Thresholds and options reviewed with him today; preferences unchanged; report sent to vascular surgery, with review at one year |
| Examination | Blood pressure, target below 130/80 | Every visit | Completed today | 124/76 mmHg; at target |
| Self-management | Home blood pressure readings | Before each visit while treatment is being adjusted | Completed today | Home average 122/74 |
| Laboratory | Metabolic panel (sodium, potassium, creatinine, eGFR) | 2 to 4 weeks after starting or changing losartan; then every 6 months | Up to date | Normal ten weeks ago; next due in about four months, by standing order |
| Laboratory | Lipid panel | 4 to 12 weeks after starting a statin; then yearly | Up to date | LDL 62 mg/dL ten weeks ago; repeat yearly |
| Laboratory | ALT | Once before a statin; then only with symptoms | Not indicated | No symptoms |
| Laboratory | HbA1c | Yearly | Up to date | 5.6 percent six months ago; due at one year |
| Laboratory | Urine albumin-to-creatinine ratio | Yearly | Up to date | 14 mg/g six months ago; due at one year |
| Medication safety | Statin adherence and muscle symptoms | Every visit | Completed today | Adherent; no muscle aches |
| Medication safety | Low-dose aspirin: indication and bleeding | Every visit while taking it | Completed today | No bleeding or bruising |
| Medication safety | Medication review: avoid fluoroquinolones and anti-inflammatory pain medicines | Every visit | Completed today | No anti-inflammatory or fluoroquinolone use |
| Self-management | Tobacco use and cessation support (5 A's, nicotine replacement) | Every visit | Completed today | Tobacco-free nearly six months; nicotine replacement finished |
| Examination | 12-lead ECG | Baseline with hypertension; repeat as indicated | Up to date | Normal five months ago |
| Examination | Ankle-brachial index | Every 2 to 3 years at 65 or older or with a smoking history | Completed today | Ankle-brachial index with today's scan: 1.04 on the right and 1.02 on the left, normal |
| Examination | Eye examination for hypertensive retinopathy | Yearly | Due | Examination booked for next month |
| Examination | Weight and BMI | Every visit | Completed today | 79.8 kg; BMI 27.0 |
Goal progress:
Guideline basis: The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm (2018); 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease (2022); CMID: Clinical Monitoring Intelligence Database, Hypertension and Hyperlipidemia monographs (2026); Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions (2021)
Follow-up: Metabolic panel in about four months by standing order. Aneurysm surveillance with duplex ultrasound in six months. Vascular surgery review at one year. Annual wellness visit next summer. [S]